Join the Nonalcoholic Fatty Liver Disease group to help and get support from people like you.
Nonalcoholic Fatty Liver Disease News
Related terms: Nonalcoholic Steatohepatitis, Idiopathic Fatty Liver, Steatosis, Steatohepatitis, Fatty Liver, NASH, NAFLD, MASLD, Metabolic Dysfunction-Associated Steatotic Liver Disease
GLP-1 RA Reduces Severity of Steatotic Liver Disease in People With HIV
MONDAY, March 18, 2024 – For people with HIV (PWH) with metabolic-associated steatotic liver disease (MASLD), semaglutide is associated with absolute and relative declines in intrahepatic...
FDA Approves Rezdiffra, First Specific Treatment for Nonalcoholic Steatohepatitis
FRIDAY, March 15, 2024 – On Thursday, the U.S. Food and Drug Administration announced the approval of Rezdiffra (resmetirom) to treat noncirrhotic nonalcoholic steatohepatitis (NASH) with...
FDA Grants Accelerated Approval for Rezdiffra (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH)
CONSHOHOCKEN, Pa., March 14, 2024 (GLOBE NEWSWIRE) – Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic...
FDA Approves First Drug for Common, Serious Liver Disease, Rezdiffra
FRIDAY, March 15, 2024 – Millions of Americans whose livers develop scar tissue due to a common disease now have the first approved drug, Rezdiffra, to treat the condition, the U.S. Food and Drug...
NASH Resolution Increased, Improvement of Fibrosis Seen With Resmetirom
THURSDAY, Feb. 8, 2024 – For patients with nonalcoholic steatohepatitis (NASH) and fibrosis stage F1B, F2, or F3, 80- and 100-mg resmetirom is better than placebo, according to a study published in...
Pegozafermin Leads to Improvements in Fibrosis in NASH
FRIDAY, June 30, 2023 – For patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH) and stage F2 or F3 fibrosis, treatment with pegozafermin leads to improvements in fibrosis, according...
Cases of Obesity-Linked Liver Disease Rising Steeply Among Americans
MONDAY, June 19, 2023 (HealthDay news) – Fatty liver disease is increasing rapidly among Americans, outpacing obesity rates across many racial groups and affecting the liver health of millions, a...
Bariatric-Metabolic Surgery Effective for Nonalcoholic Steatohepatitis Treatment
WEDNESDAY, May 3, 2023 – For patients with nonalcoholic steatohepatitis (NASH), bariatric-metabolic surgery is more effective than lifestyle modification plus best medical care, according to a study...
ChatGPT Provides Some Helpful Responses for Liver Diseases
FRIDAY, April 28, 2023 – ChatGPT provides easy-to-understand information about basic knowledge, lifestyle, and treatments for cirrhosis and liver cancer, according to a study published online March...
Ask a question
To post your own question to this support group, sign in or create an account.